Organization · Venture Capital
ScienceFlow
ScienceFlow is a venture capital organization based in Donostia, Spain, focusing on early-stage biotechnology companies. It aims to support life science discoveries and provide investment opportunities in the biotech sector.
Overview
What ScienceFlow does
What ScienceFlow is
ScienceFlow is a venture capital organization based in Donostia, Spain, focusing on early-stage biotechnology companies. It aims to support life science discoveries and provide investment opportunities in the biotech sector.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Structured capabilities
- Funder
- Last reviewed
- May 1, 2026
Official channels
Find ScienceFlow elsewhere
Open the official website or a supported primary organization account.
Capability profile
ScienceFlow as a funder
Investment thesis
ScienceFlow focuses on early-stage biotechnology companies from strong life-sciences hubs, emphasizing scientific diligence and addressing unmet needs in high-growth markets with a defined exit strategy of up to four years.
Focus narrative
ScienceFlow focuses its investments on early-stage biotechnology companies located in prominent life sciences hubs. The organization employs a consistent investment strategy that evaluates scientific research, intellectual property, and competitive technologies, aiming to address unmet needs in high-growth markets.
Value beyond capital
ScienceFlow adds value to its portfolio companies through its deep expertise in scientific research and biotechnology, providing strategic guidance and support in navigating the complexities of the life sciences market.
Focus and fit
- Stages
- Pre-seed · Seed · Seed+ · Series A · Series A+ · Series B · Series B+ · Series C · Series C+ · Series D · Series E · Series F · Growth Equity
- Sectors
- Biotech · Healthcare · Medical Devices
- Regions
- Europe · Global
Availability
- Currently deploying
- Not published
Portfolio and track record
- Recorded portfolio count
- 8
Portfolio context
Notable portfolio companies include: Nido Biosciences: Developing small-molecule therapeutics for neurodegenerative diseases (Series B). Astrocyte Pharma: Focused on drug development for neuroprotective benefits through selective astrocyte activation (Series B). Chimeron Bio: Innovating self-amplifying RNA therapeutics and vaccines (Series A). Inspirna: Clinical-stage biopharma developing cancer drugs inspired by RNA biology (Series D). OcuTerra Therapeutics: Developing drugs for ophthalmic diseases (Series B). Elicio Therapeutics: Targeting lymph nodes with immunotherapies and vaccines for cancer and infectious diseases (Series B and C). Aardvark Therapeutics: Clinical-stage small-molecule therapeutics company (Series B). Therini Bio: Developing therapies for chronic neuroinflammation and neuronal damage (Series A).
Common questions
What to know about ScienceFlow
Upseed classifies ScienceFlow under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 1, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.